Sentence examples for testing the prognostic value from inspiring English sources

Through an algorithm-based approach, Roses and team are testing the prognostic value of the TOMM40 genotype, APOE variants and age for patient inclusion in a trial of pioglitazone in normal subjects.

In total, there were 393 possible subpopulations (see Additional file 1 for an exhaustive listing), of which only those with more than N = 20 samples were further considered for testing the prognostic value of the BRAF and KRAS mutations.

The aim of this study was to test the prognostic value of both the original and the modified 2010 WHO grading systems.

There is a need to test the prognostic value of factors that could be used for guiding therapy after the initial resuscitation.

To test the prognostic value of 6-hour Scv02, the area under receiver operating characteristics curve (AUROC) to predict 1-month mortality was calculated and compared with that of 6-hour lactate level.

Secondary aim of this study was to test the prognostic value of SUV and SUR in comparison to K slope in a homogeneous subgroup (N=31) of patients with NSCLC which underwent primary chemoradiation.

Path analysis methods were used to test the prognostic value of 10 patient-related and treatment-related factors on the 1-year functional outcome of 463 proximal humeral fractures measured using the Constant score.

As a sensitivity analysis, we tested the prognostic value of LIS in two 'severe ARDS' subgroups as defined as (1) LIS ≥ 3, a cut-point used to identify 'refractory ARDS' for consideration of possible rescue therapies; [11 13] and (2) PEEP values ≥ 10 cm H2O, a cutoff which has been associated with improved consistency in measurement of hypoxemia [24].

To our knowledge no prior study has tested the prognostic value of PMC deactivation in MCI.

We tested the prognostic value of ALDH1 using a tissue array of serous ovarian cancers, the most common histotype of human epithelial ovarian cancer.

Moreover, Roth et al. [Proc Am Soc Clin Oncol Gastrointestinal Cancers Symposium 206, 2009; Abstr 288] tested the prognostic value per stage of KRAS and BRAF mutations using CRC tumor samples from the adjuvant PETACC3 trial, and they found no significant effects on relapse-free survival for both mutations, neither in stage II nor in stage III.